Skip to content

Application of rimazolom toluenesulfonate for injection in painless ERCP: a randomized controlled trial.

Application of rimazolom toluenesulfonate for injection in painless ERCP

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034711
Enrollment
Unknown
Registered
2020-07-16
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless ERCP

Interventions

Sponsors

Xinxiang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I ~ II; 2. Age 25-65 years old; 3. BMI 18-30 kg / m2; 4. Willing to accept the anesthesia program and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are participating in or planning to participate in any intervention clinical trial; 2. Psychotic patients and others without complete civil capacity; 3. Those who have recently taken analgesics and sedatives or received other drug treatment, or have alcohol or drug dependence; 4. Pregnant or lactating women; 5. Have allergic history or severe allergic constitution to test drugs; 6. Other situations that may cause adverse consequences.

Design outcomes

Primary

MeasureTime frame
RR;SBP, DBP, MAP;Spo2;HR;modified observer's assessment of alert /sedation;BIS;

Secondary

MeasureTime frame
Intraoperative and postoperative adverse reactions;Total sedatives;Number of additional sedatives;Anesthesia induction time;Recovery time;Time to leave recovery room;Patient satisfaction score;Satisfaction of Surgeons;

Countries

China

Contacts

Public ContactZhao Lifang

Xinxiang Central Hospital

zhaolifanggong@sina.cn+86 17637306373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026